Ohnishi K - Search Results

1

Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system.

Kizaki M, Takahashi N, Iriyama N, Okamoto S, Ono T, Usui N, Inokuchi K, Nakaseko C, Kurokawa M, Sumi M, Nakamura F, Kawaguchi T, Suzuki R, Yamamoto K, Ohnishi K, Matsumura I, Naoe T; New TARGET investigators. Kizaki M, et al. Among authors: ohnishi k. Int J Hematol. 2019 Apr;109(4):426-439. doi: 10.1007/s12185-019-02613-1. Epub 2019 Feb 14. Int J Hematol. 2019. PMID: 30762219 Clinical Trial.

2

Multicenter prospective study of interferon alpha versus allogeneic stem cell transplantation for patients with new diagnoses of chronic myelogenous leukemia.

Ohnishi K, Ino A, Kishimoto Y, Usui N, Shimazaki C, Ohtake S, Taguchi H, Yagasaki F, Tomonaga M, Hotta T, Ohno R; Japan Adult Leukemia Study Group. Ohnishi K, et al. Int J Hematol. 2004 May;79(4):345-53. doi: 10.1532/ijh97.03160. Int J Hematol. 2004. PMID: 15218963 Clinical Trial.

3

Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical study.

Morishima Y, Ogura M, Nishimura M, Yazaki F, Bessho M, Mizoguchi H, Chiba S, Hirai H, Tauchi T, Urabe A, Takahashi M, Ohnishi K, Yokozawa T, Emi N, Hirano M, Shimazaki C, Nakao S, Kawai Y, Fujimoto M, Taguchi H, Jinnai I, Ohno R. Morishima Y, et al. Among authors: ohnishi k. Int J Hematol. 2004 Oct;80(3):261-6. doi: 10.1532/ijh97.04074. Int J Hematol. 2004. PMID: 15540902 Clinical Trial.

4

Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies.

Shigeno K, Naito K, Sahara N, Kobayashi M, Nakamura S, Fujisawa S, Shinjo K, Takeshita A, Ohno R, Ohnishi K. Shigeno K, et al. Among authors: ohnishi k. Int J Hematol. 2005 Oct;82(3):224-9. doi: 10.1532/IJH97.05044. Int J Hematol. 2005. PMID: 16207595 Clinical Trial.

5

[Clinical course of the disease and the level of WT1 mRNA in 191 patients with acute myeloid leukemia (AML): joint research by 23 institutions in Japan].

Miyawaki S, Emi N, Mitani K, Oyashiki K, Kitamura K, Morishita T, Ogawa H, Komatsu N, Soma T, Tamaki T, Kosugi H, Ohnishi K, Mizoguchi H, Hiraoka A, Kodera Y, Ueda R, Morishima Y, Nakagawa M, Tobita T, Sugimoto K, Chiba S, Inoue N, Hamaguchi M, Koga D, Tamaki H, Naoe T, Sugiyama H, Takaku F. Miyawaki S, et al. Among authors: ohnishi k. Rinsho Ketsueki. 2005 Dec;46(12):1279-87. Rinsho Ketsueki. 2005. PMID: 16447800 Japanese.

6

Two patients with all-trans retinoic acid-resistant acute promyelocytic leukemia treated successfully with gemtuzumab ozogamicin as a single agent.

Takeshita A, Shinjo K, Naito K, Matsui H, Sahara N, Shigeno K, Suzumura T, Horii T, Shirai N, Maekawa M, Yada Y, Teshima H, Takeuchi J, Ohnishi K, Ohno R. Takeshita A, et al. Among authors: ohnishi k. Int J Hematol. 2005 Dec;82(5):445-8. doi: 10.1532/IJH97.05069. Int J Hematol. 2005. PMID: 16533750

7

Role for interleukin-6 and insulin-like growth factor-I via PI3-K/Akt pathway in the proliferation of CD56- and CD56+ multiple myeloma cells.

Sahara N, Takeshita A, Ono T, Sugimoto Y, Kobayashi M, Shigeno K, Nakamura S, Shinjo K, Naito K, Shibata K, Otsuki T, Hayashi H, Ohnishi K. Sahara N, et al. Among authors: ohnishi k. Exp Hematol. 2006 Jun;34(6):736-44. doi: 10.1016/j.exphem.2006.02.012. Exp Hematol. 2006. PMID: 16728278 Free article.

8

Clinicopathological and prognostic characteristics of CD33-positive multiple myeloma.

Sahara N, Ohnishi K, Ono T, Sugimoto Y, Kobayashi M, Takeshita K, Shigeno K, Nakamura S, Naito K, Tamashima S, Nara K, Tobita T, Takeshita A, Ohno R. Sahara N, et al. Among authors: ohnishi k. Eur J Haematol. 2006 Jul;77(1):14-8. doi: 10.1111/j.1600-0609.2006.00661.x. Eur J Haematol. 2006. PMID: 16827882

9

[The management of chronic phase CML].

Ohnishi K. Ohnishi K. Nihon Rinsho. 2007 Jan 28;65 Suppl 1:499-504. Nihon Rinsho. 2007. PMID: 17474455 Review. Japanese. No abstract available.

10

[An advance in the treatment of CML].

Ohnishi K. Ohnishi K. Gan To Kagaku Ryoho. 2007 Dec;34(13):2185-90. Gan To Kagaku Ryoho. 2007. PMID: 18079618 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,409 results

Search Page